Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-008077

Options or other derivatives

  • Director acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shegog Todd Director 2021-02-22 Grant or award · Stock Option (Right to Buy) +37,500 37,500 D
Loading xslF345X03/doc4.xml…